Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased due to higher product prices resulting from inflation and sales strategies, growth in focus categories such as health and beauty and pet products, expansion of exclusive and priority-distribution products as well as large-volume and high-value-added products, and increased business with new retailers. Profit declined due to sluggish sales volume, higher center fees and other costs, delays in measures to control selling, general and administrative expenses, and increases in personnel, logistics and rent expenses.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥1,004,749 million (YoY +1.9%) |
| Operating profit | ¥13,207 million (YoY -11.9%) |
| Ordinary income | ¥13,534 million (YoY -13.3%) |
| Profit attributable to owners of the parent | ¥10,130 million (YoY -2.2%) |
| Net income per share | ¥302.76 |
| Operating Margin | 1.3％ |
| Equity ratio | End of the current fiscal period 35.7 / End of previous period 37.4 |
| Total assets | ¥347,880 million |
| Net assets | ¥124,162 million |
| Cash flows from operating activities | ¥18,694 million |
| Cash flows from investing activities | ¥-12,787 million |
| Cash flows from financing activities | ¥10,117 million |
| Cash and cash equivalents at end of period | ¥38,623 million |
| Full-year earnings forecast | Net Sales ¥1,030,000 million (YoY +2.5%) / Operating profit ¥11,000 million (YoY -16.7%) / Ordinary income ¥10,500 million (YoY -22.4%) / Profit attributable to owners of the parent ¥7,000 million (YoY -30.9%) |
| Annual Dividend Forecast | ¥102 → ¥112（+9.8%） |
| Payout ratio | 53.5 |
| Depreciation and amortization | ¥4,862 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥599 million, Gain on sale of investment securities ¥874 million / Extraordinary loss Loss on sale of fixed assets ¥85 million, Loss on Disposal of Fixed Assets ¥15 million, Impairment Loss on Investment Securities ¥149 million, Loss on sale of investment securities ¥0 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 3 / Company name 株式会社MAPホールディングス, msh株式会社, 株式会社Polite / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors, analysts and financial institutions |
| Issued Shares at Period-End | 36,057,424 |
| Treasury Shares at Period-End | 2,580,712 |
| Factors Behind Changes in Business Performance | Revenue increased due to higher product prices resulting from inflation and sales strategies, growth in focus categories such as health and beauty and pet products, expansion of exclusive and priority-distribution products as well as large-volume and high-value-added products, and increased business with new retailers. Profit declined due to sluggish sales volume, higher center fees and other costs, delays in measures to control selling, general and administrative expenses, and increases in personnel, logistics and rent expenses. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although product prices rose due to inflation and sales strategies, sales volume failed to grow amid changes in consumer trends and other factors, slowing revenue growth. On the profit side, the company explained that the increase in center fees and other costs, delays in measures to control selling, general and administrative expenses, and higher personnel, logistics and rent expenses weighed on results.